Market Whales and Their Recent Bets on GILD Options
Market Whales and Their Recent Bets on GILD Options
Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead Sciences (NASDAQ:GILD) revealed 13 unusual trades.
金融巨头对吉利德科学采取了明显的看涨举动。我们对吉利德科学（纳斯达克股票代码：GILD）期权历史的分析显示了13笔不寻常的交易。
Delving into the details, we found 61% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $495,955, and 6 were calls, valued at $263,160.
深入研究细节，我们发现61％的交易者看涨，而23％的交易者表现出看跌倾向。在我们发现的所有交易中，有7笔是看跌期权，价值为495,955美元，6笔是看涨期权，价值263,160美元。
Predicted Price Range
预测的价格区间
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $90.0 for Gilead Sciences over the recent three months.
根据交易活动，看来重要投资者的目标是在最近三个月中将吉利德科学的价格范围从55.0美元扩大到90.0美元。
Volume & Open Interest Development
交易量和未平仓合约的发展
In today's trading context, the average open interest for options of Gilead Sciences stands at 1270.25, with a total volume reaching 3,306.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Gilead Sciences, situated within the strike price corridor from $55.0 to $90.0, throughout the last 30 days.
在当今的交易背景下，吉利德科学期权的平均未平仓合约为1270.25，总成交量达到3,306.00。随附的图表描绘了过去30天内吉利德科学高价值交易的看涨和看跌期权交易量以及未平仓合约的变化，行使价走势从55.0美元到90.0美元不等。
Gilead Sciences Option Activity Analysis: Last 30 Days
吉利德科学期权活动分析：过去 30 天
Noteworthy Options Activity:
值得注意的期权活动：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD | PUT | SWEEP | BULLISH | 01/17/25 | $4.05 | $3.9 | $3.9 | $65.00 | $102.9K | 2.5K | 266 |
| GILD | CALL | SWEEP | BULLISH | 06/20/25 | $4.95 | $4.85 | $4.95 | $72.50 | $95.0K | 122 | 194 |
| GILD | PUT | SWEEP | BEARISH | 11/15/24 | $5.55 | $5.45 | $5.55 | $70.00 | $90.4K | 428 | 172 |
| GILD | PUT | TRADE | BEARISH | 06/20/25 | $2.3 | $2.12 | $2.3 | $55.00 | $75.8K | 1.0K | 332 |
| GILD | PUT | TRADE | BEARISH | 01/17/25 | $1.21 | $1.17 | $1.2 | $55.00 | $63.6K | 2.4K | 530 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 金 | 放 | 扫 | 看涨 | 01/17/25 | 4.05 美元 | 3.9 美元 | 3.9 美元 | 65.00 美元 | 102.9 万美元 | 2.5K | 266 |
| 金 | 打电话 | 扫 | 看涨 | 06/20/25 | 4.95 美元 | 4.85 美元 | 4.95 美元 | 72.50 美元 | 95.0 万美元 | 122 | 194 |
| 金 | 放 | 扫 | 粗鲁的 | 11/15/24 | 5.55 美元 | 5.45 美元 | 5.55 美元 | 70.00 美元 | 90.4 万美元 | 428 | 172 |
| 金 | 放 | 贸易 | 粗鲁的 | 06/20/25 | 2.3 美元 | 2.12 美元 | 2.3 美元 | 55.00 美元 | 75.8 万美元 | 1.0K | 332 |
| 金 | 放 | 贸易 | 粗鲁的 | 01/17/25 | 1.21 美元 | 1.17 | 1.2 美元 | 55.00 美元 | 63.6 万美元 | 2.4K | 530 |
About Gilead Sciences
关于吉利德科学
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
吉利德科学开发和销售治疗危及生命的传染病的疗法，其产品组合的核心集中在艾滋病毒以及乙型和丙型肝炎上。对Corus Pharma、Myogen、CV Therapeutics、Arresto Biosciences和Calistoga的收购扩大了这一关注范围，将肺部和心血管疾病以及癌症包括在内。吉利德对Pharmasset的收购带来了丙型肝炎药物Sovaldi的版权，该药物也是复方药物Harvoni的一部分，而对Kite、Forty Seven和Immunomedics的收购增加了吉利德在肿瘤学领域接受细胞疗法和非细胞疗法的机会。
In light of the recent options history for Gilead Sciences, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鉴于吉利德科学最近的期权历史，现在应该专注于公司本身。我们的目标是探索其目前的表现。
Present Market Standing of Gilead Sciences
吉利德科学目前的市场地位
- With a volume of 1,845,363, the price of GILD is up 0.09% at $67.71.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 78 days.
- GILD的交易量为1,845,363美元，上涨0.09％，至67.71美元。
- RSI指标暗示标的股票可能接近超买。
- 下一份财报预计将在78天后公布。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Gilead Sciences with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro了解吉利德科学的最新期权交易，以获取实时警报。
译文内容由第三方软件翻译。